Joint Formulary & PAD

Didanosine - HIV infection

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Dispersible tablets
  • Tablets
Associated Icons :
BNF SPC
NHSE
R
Restrictions / Comments :
Important
Restricted Antimicrobial - requires GUM Specialist approval

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Didanosine
Indication :
HIV infection
Group Name :
Keywords :
antiviral
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Didanosine is used to treat.

  • No records returned.

Committee Recommendations (1)

These drugs falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication